Australia | Part 1: Patenting orphan drugs
Collectively, rare diseases impact approximately 8% of the Australian population, or around 2 million people. Orphan drugs are pharmaceutical products developed to treat rare diseases, however with each drug...
Collectively, rare diseases impact approximately 8% of the Australian population, or around 2 million people. Orphan drugs are pharmaceutical...
Read More
Review of AU Pharmaceutical Patent Term Extensions (PTEs)
The current provisions in the Australian Patents Act providing for extensions of term for pharmaceutical patents were introduced in 1998. They provide for an effective 15 year patent life...
The current provisions in the Australian Patents Act providing for extensions of term for pharmaceutical patents were introduced in...
Read More